Indication

Chronic hepatitis C - genotype 5

Chronic hepatitis C - genotype 5 is a persistent, bloodborne viral infection of the liver caused by the hepatitis C virus (HCV) classified specifically within genetic clade 5 (predominantly subtype 5a). Read more about Chronic hepatitis C - genotype 5

6 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Chronic hepatitis C - genotype 5 therapies.

Showing 1–6 of 6 drugs

Filter & compare in the drug finder →Opens the drug finder with Chronic hepatitis C - genotype 5 preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic hepatitis C - genotype 5.

Chronic hepatitis C - genotype 5 is a persistent, bloodborne viral infection of the liver caused by the hepatitis C virus (HCV) classified specifically within genetic clade 5 (predominantly subtype 5a).

While clinically uncommon globally, it is notably endemic in regions of southern Africa and observed in specific focal clusters in parts of Europe.

Pathophysiologically, the virus replicates within hepatocytes, evading the host immune response and driving chronic hepatic inflammation.

Although often clinically silent or mildly symptomatic in early stages, chronic infection leads to progressive fibrosis, cirrhosis, hepatic decompensation, and hepatocellular carcinoma over decades.

Identifying genotype 5 via molecular testing is clinically critical to guide the selection and duration of antiviral therapies with appropriate pan-genotypic or genotype-specific regimens.

Personalize your experience

Follow Chronic hepatitis C - genotype 5 and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it